Risankizumab for Induction and Maintenance of Remission in Ulcerative Colitis. Roshanov PS, Khanna R. Gastroenterology 2024 Sep 7:S0016-5085(24)05444.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Roshanov PS, Khanna R. Risankizumab for Induction and Maintenance of Remission in Ulcerative Colitis. Gastroenterology 2024 Sep 7:S0016-5085(24)05444.
PMID: 39251167